Abbott Laboratories (ABT) Net Cash Flow (QoQ) (2009 - 2026)
Analysis
Abbott Laboratories (ABT) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.79 Bn | 179.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.38 Bn | 119.16 Bn | 1.96 Bn |
| 3 | Medtronic | 118.45 Bn | 109.63 Bn | 6.34 Bn |
| 4 | Stryker | 105.32 Bn | 101.84 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.71 Bn | 66.17 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.56 Bn | 1.35 Bn |
| 7 | Alcon | 34.03 Bn | 32.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.41% |
| Mar 31, 2026 | -268.76% |
| Dec 31, 2025 | 76.32% |
| Sep 30, 2025 | 54.89% |
| Jun 30, 2025 | 133.21% |
| Mar 31, 2025 | -885.82% |
| Dec 31, 2024 | -73.64% |
| Sep 30, 2024 | -25.28% |
| Jun 30, 2024 | 224.31% |
| Mar 31, 2024 | -455.56% |
| Dec 31, 2023 | 114.77% |
| Sep 30, 2023 | 15.55% |
| Jun 30, 2023 | -78.19% |
| Mar 31, 2023 | -407.59% |
| Dec 31, 2022 | -68.53% |
| Sep 30, 2022 | -43.51% |
| Jun 30, 2022 | 162.94% |
| Mar 31, 2022 | -515.29% |
| Dec 31, 2021 | -24.22% |
| Sep 30, 2021 | 12.17% |